Literature DB >> 8287990

Extensive visual loss with topical facial steroids.

R K Aggarwal1, T Potamitis, N H Chong, M Guarro, P Shah, S Kheterpal.   

Abstract

Steroid creams applied topically to the skin are routinely used in the treatment of many dermatoses. Their use on the face in severe atopic eczema is relatively common. We report a series of three patients who whilst using topical facial steroids developed advanced glaucoma. A further two cases of ocular hypertension secondary to topical facial steroids are also described. This is the first series of cases to be reported demonstrating the potentially blinding complications of topical facial steroids. Recommendations are made with regard to screening such patients for glaucoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287990     DOI: 10.1038/eye.1993.152

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

1.  Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.

Authors:  H Schäcke; T M Zollner; W D Döcke; H Rehwinkel; S Jaroch; W Skuballa; R Neuhaus; E May; U Zügel; K Asadullah
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

2.  Case report: visual loss caused by facial steroids.

Authors:  A Michaeli-Cohen; M Neudorfer; A Loewenstein; M Lazar; O Geyer
Journal:  Can Fam Physician       Date:  1998-11       Impact factor: 3.275

Review 3.  Management of atopic eczema. Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London.

Authors:  P M McHenry; H C Williams; E A Bingham
Journal:  BMJ       Date:  1995-04-01

4.  Periocular steroid ointments may cause ocular damage.

Authors:  C J McLean; R F Lobo; D J Brazier
Journal:  BMJ       Date:  1994 Aug 20-27

5.  Glaucoma induced by steroids.

Authors:  N H Chong
Journal:  BMJ       Date:  1994-07-30

6.  Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis.

Authors:  Eric Hyun; Manlio Bolla; Martin Steinhoff; John L Wallace; Piero Del Soldato; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2004-08-16       Impact factor: 8.739

7.  Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study.

Authors:  Michael W Marcus; Rogier P H M Müskens; Wishal D Ramdas; Roger C W Wolfs; Paulus T V M De Jong; Johannes R Vingerling; Albert Hofman; Bruno H C Stricker; Nomdo M Jansonius
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

Review 8.  Clinical characteristics and current treatment of glaucoma.

Authors:  Laura P Cohen; Louis R Pasquale
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

9.  Facial eczema and sight-threatening glaucoma.

Authors:  Jonathan J Ross; Aby Jacob; Mark Batterbury
Journal:  J R Soc Med       Date:  2004-10       Impact factor: 18.000

10.  Intraocular pressure variation in patients on long-term corticosteroids.

Authors:  John Shekhar Raju Mandapati; Arun Kumar Metta
Journal:  Indian Dermatol Online J       Date:  2011-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.